Savara Inc. Daily Stock Analysis

Daily Stock Analysis, SVRA, Savara Inc, priceseries

Savara Inc. Daily Stock Analysis
Stock Information
Open
1.12
Close
1.10
High
1.13
Low
1.09
Previous Close
1.10
Daily Price Gain
0.00
YTD High
1.37
YTD High Date
Jan 4, 2022
YTD Low
1.02
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.26
YTD Gain
-19.12%
52 Week High
3.58
52 Week High Date
Mar 16, 2021
52 Week Low
1.02
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-0.56
52 Week Gain
-33.73%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 23. 2017
7.49
Apr 18. 2017
9.26
17 Trading Days
23.64%
Link
LONG
Jun 8. 2017
5.49
Jun 29. 2017
6.17
15 Trading Days
12.39%
Link
LONG
Sep 5. 2017
5.63
Oct 9. 2017
9.06
24 Trading Days
60.88%
Link
LONG
Nov 10. 2017
9.53
Dec 26. 2017
15.14
30 Trading Days
58.84%
Link
LONG
Apr 1. 2019
7.90
Apr 15. 2019
8.82
10 Trading Days
11.66%
Link
LONG
Apr 18. 2019
9.32
May 9. 2019
10.57
14 Trading Days
13.45%
Link
LONG
Dec 11. 2019
1.21
Jan 21. 2020
3.60
26 Trading Days
197.84%
Link
LONG
Apr 8. 2020
2.08
Apr 21. 2020
2.30
8 Trading Days
10.68%
Link
LONG
Nov 19. 2020
1.16
Dec 10. 2020
1.31
14 Trading Days
12.90%
Link
LONG
Mar 15. 2021
1.77
Mar 22. 2021
1.91
5 Trading Days
7.91%
Link
LONG
Aug 23. 2021
1.29
Sep 7. 2021
1.43
10 Trading Days
11.17%
Link
Company Information
Stock Symbol
SVRA
Exchange
NYSE MKT
Company URL
http://www.masttherapeutics.com
Company Phone
512-614-1848
CEO
Brian M. Culley
Headquarters
Texas
Business Address
900 S. CAPITAL OF TEXAS HIGHWAY, SUITE 150, AUSTIN, TX 78746
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001160308
About

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.

Description

Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. Its lead product candidate is AIR001, a sodium nitrite solution for inhalation through nebulization, which is in Phase II clinical stage for the treatment of heart failure with preserved ejection fraction, as well as in Phase I/II study in patients with cystic fibrosis. The company was formerly known as ADVENTRX Pharmaceuticals, Inc. and changed its name to Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading